Unknown PHASE4 INTERVENTIONAL 2-arm NCT03864588

Comparing Ropivacaine Adductor Canal Blockade by Surgeon Versus Anesthesiologist

A Randomized Controlled Trial Comparing Intraoperative Surgeon-Performed Versus Anesthesiologist-Performed Adductor Canal Blockade After Primary Total Knee Arthroplasty

Sponsor: Rothman Institute Orthopaedics

Conditions Pain, Postoperative Satisfaction

Interventions Ropivacaine

Updated 5 times since 2019 Last updated: Mar 4, 2019 Started: Oct 1, 2018 Primary completion: Jun 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain, Postoperative and Satisfaction and is currently ongoing. Rothman Institute Orthopaedics leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Enrolling By Invitation → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Enrolling By Invitation PHASE4
Apr 2019 — Jan 2021 [monthly]

Enrolling By Invitation PHASE4

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rothman Institute Orthopaedics
Sharpe-Strumia Research Foundation

Data source: Rothman Institute Orthopaedics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States